Skip to main content
Have a personal or library account? Click to login
Multidrug-Resistant Salmonella and Shigella: Epidemiology, Resistance Mechanisms, and Emerging Therapeutic Strategies Cover

Multidrug-Resistant Salmonella and Shigella: Epidemiology, Resistance Mechanisms, and Emerging Therapeutic Strategies

Open Access
|Jun 2026

References

  1. Alshaibani MKM. 1994. A Shigella outbreak in Barshash. Saudi Field Epidemiol Train Program. Available from: https://www.saudifetp.org/seb/shigella-outbreak-barshash
  2. Ackermann HW. 2006. Classification of bacteriophages. In: Calendar R, editor. The bacteriophages. 2nd ed. New York (NY): Oxford University Press. p. 8–16.
  3. Al-Ansari MM, Aljubali MM, Somily AM, Albarrag AM, Masood A. 2021. Isolation and molecular characterization of multidrug-resistant Salmonella enterica serovars. J Infect Public Health. 14(12):1767–1776. https://doi.org/10.1016/j.jiph.2021.10.012
  4. Alenazy R. 2022. Antibiotic resistance in Salmonella: targeting multidrug resistance by understanding efflux pumps, regulators and the inhibitors. J King Saud Univ Sci. 34(7):102275. https://doi.org/10.1016/j.jksus.2022.102275
  5. Alfaleh A, Alkattan A, Alzaher A, Sagor K, Almarshoud S, Ibrahim MH. 2025. Infectious foodborne disease outbreaks and sporadic cases in Saudi Arabia: a 2017–2023 trend analysis. Infect Dis Now. 55:105079. https://doi.org/10.1016/j.idnow.2025.105079
  6. Alharthi H, Al-Ghamdi G, Alpakistany T, Almiman B, Alghamdi AM, Albaldi FO, Alzahrani SA, Alshammari AA, Alqahtani KM, Gazi KS. 2025. A novel multidrug-resistant Salmonella enterica strain (A10) isolated from eggshells in wet markets of Taif, Saudi Arabia. J Appl Biol Biotechnol. 13(6):16. https://doi.org/10.7324/JABB.2025.v13.i6.16
  7. Alhumaidan OS. 2024. Comprehensive review of salmonellosis: current status of the disease and future perspectives. Ital J Food Saf. 13(4):12904. https://doi.org/10.4081/ijfs.2024.12904
  8. Aljasir SF, Allam SA. 2025. Prevalence and antibiotic resistance of Salmonella spp. and Campylobacter spp. isolated from retail chickens in Saudi Arabia. Microbiol Res. 16(1):27. https://doi.org/10.3390/microbiolres16010027
  9. Allison DG, Lambert PA. 2024. Modes of action of antibacterial agents. In: Molecular medical microbiology. 3rd ed. London: Academic Press. p. 597–614.
  10. Al-maaqar SM, Al Johni ARS, Al-Tayyar NA, Alhamad JA, Ghyathuddin AAK, Alsubhi WA, Alzahrani SA, Alharbi AA, Alzahrani AA, Khormi MA. 2025. Bdellovibrio bacteriovorus: a “magic weapon” against bacterial pathogens. Ann Microbiol. 75(1):11. https://doi.org/10.1186/s13213-025-01794-x
  11. Almujaidel A, Abalkhail A, Elbehiry A. 2025. Prevalence, characterization, and transmissible factors of foodborne pathogens in the Al-Qassim region, Saudi Arabia. Cell Mol Biol (Noisy-le-grand). 71(8):48–59.
  12. Almuzaini AM. 2023. Phytochemicals: potential alternative strategy to fight Salmonella enterica serovar Typhimurium. Front Vet Sci. 10:1188752. https://doi.org/10.3389/fvets.2023.1188752
  13. Amare A, Eshetie S, Kasew D, Abebe W, Moges F. 2024. Prevalence of Salmonella spp., Shigella spp., and intestinal parasites among food handlers working in University of Gondar cafeteria. Front Public Health. 12:1370338. https://doi.org/10.3389/fpubh.2024.1370338
  14. Anwar Y, Jaha HF, Ul-Islam M, Kamal T, Khan SB, Ullah I, Ahmed S. 2024. Development of silver-doped copper oxide and chitosan nanocomposites for enhanced antimicrobial activities. Z Naturforsch C J Biosci. 79(5–6):137–148. https://doi.org/10.1515/znc-2023-0182
  15. Ayobola ED, Oscar WO, Ejovwokoghene EF. 2021. Occurrence of plasmid-mediated fluoroquinolone resistance genes among enteric bacteria isolated from human and animal sources in Delta State, Nigeria. AIMS Microbiol. 7(1):75–89. https://doi.org/10.3934/microbiol.2021005
  16. Bassetti M, Peghin M, Vena A, Giacobbe DR. 2019. Treatment of infections due to MDR Gram-negative bacteria. Front Med (Lausanne). 6:74. https://doi.org/10.3389/fmed.2019.00074
  17. Beshiru A, Igbinosa IH, Igbinosa EO. 2018. Biofilm formation and potential virulence factors of Salmonella strains isolated from ready-to-eat shrimps. PLoS One. 13(9):e0204345. https://doi.org/10.1371/journal.pone.0204345
  18. Birlutiu V, Birlutiu RM. 2025. An overview of the epidemiology of multidrug resistance and bacterial resistance mechanisms: what solutions are available? Microorganisms. 13(9):2194. https://doi.org/10.3390/microorganisms13092194
  19. Blaser MJ, Newman LS. 1982. A review of human salmonellosis: I. Infective dose. Rev Infect Dis. 4(6):1096–1106. https://doi.org/10.1093/clinids/4.6.1096
  20. Blaskovich MA, Cooper MA. 2025. Antibiotics re-booted: time to kick back against drug resistance. npj Antimicrob Resist. 3(1):47. https://doi.org/10.1038/s44259-025-00047-2
  21. Boudrioua A, Joiner JD, Grin I, Kronenberger T, Korotkov VS, Steinchen W, Wagner S. 2025. Discovery of synthetic small molecules targeting the central regulator of Salmonella pathogenicity. Sci Adv. 11(15):eadr5235. https://doi.org/10.1126/sciadv.adr5235
  22. Canchaya C, Fournous G, Chibani-Chennoufi S, Dillmann ML, Brüssow H. 2003. Phage as agents of lateral gene transfer. Curr Opin Microbiol. 6(4):417–424. https://doi.org/10.1016/S1369-5274(03)00086-9
  23. Caroff M, Novikov A. 2019. LPS structure, function, and heterogeneity. Methods Mol Biol. 2037:53–93. https://doi.org/10.1007/978-1-4939-9658-2_4
  24. Centers for Disease Control and Prevention. 2024. Shigella – about Shigella infection. Atlanta (GA): CDC. Available from: https://www.cdc.gov/shigella/about/index.html
  25. Centers for Disease Control and Prevention. 2024. Treatment of Shigella infection. Atlanta (GA): CDC. Available from: https://www.cdc.gov/shigella
  26. Chen X, Liu P, Wang J, He X, Wang J, Chen H, Wang G. 2024. TMT-based quantitative proteomics revealed the antibacterial mechanism of cinnamaldehyde against MRSA. J Proteome Res. 23(10):4637–4647. https://doi.org/10.1021/acs.jproteome.4c00412
  27. Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM. 2015. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin Microbiol Rev. 28(4):901–937. https://doi.org/10.1128/CMR.00002-15
  28. Davin-Regli A, Pagès JM, Vergalli J. 2024. The contribution of porins to enterobacterial drug resistance. J Antimicrob Chemother. 79(10):2460–2470. https://doi.org/10.1093/jac/dkae311
  29. Dessale M, Mengistu G, Mengist HM. 2023. Prevalence, antimicrobial resistance pattern, and associated factors of Salmonella and Shigella among children. Front Public Health. 11:1114223. https://doi.org/10.3389/fpubh.2023.1114223
  30. Dougan G, Baker S. 2014. Salmonella enterica serovar Typhi and the pathogenesis of typhoid fever. Annu Rev Microbiol. 68:317–336. https://doi.org/10.1146/annurev-micro-091313-103739
  31. Duarte-Mata DI, Salinas-Carmona MC. 2023. Antimicrobial peptides immune modulation role in intracellular bacterial infection. Front Immunol. 14:1119574. https://doi.org/10.3389/fimmu.2023.1119574
  32. Duc HM, Zhang Y, Hoang SM, Masuda Y, Honjoh KI, Miyamoto T. 2023. The use of phage cocktail and various antibacterial agents in combination to prevent the emergence of phage resistance. Antibiotics (Basel). 12(6):1077. https://doi.org/10.3390/antibiotics12061077
  33. Elhadi N. 2014. Prevalence and antimicrobial resistance of Salmonella spp. in raw retail frozen imported freshwater fish to Eastern Province of Saudi Arabia. Asian Pac J Trop Biomed. 4(3):234–238. https://doi.org/10.12980/APJTB.4.2014C1020
  34. El-Tayeb MA, Ibrahim AS, Al-Salamah AA, Almaary KS, Elbadawi YB. 2017. Prevalence, serotyping and antimicrobial resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia. Braz J Microbiol. 48(3):499–508. https://doi.org/10.1016/j.bjm.2016.12.013
  35. Ferous S, Anastassopoulou C, Pitiriga V, Vrioni G, Tsakris A. 2024. Antimicrobial and diagnostic stewardship of novel β-lactam/β-lactamase inhibitors. Antibiotics (Basel). 13(3):285. https://doi.org/10.3390/antibiotics13030285
  36. Gautret P, Benkouiten S, Sridhar S, Al-Tawfiq JA, Memish ZA. 2015. Diarrhea at the Hajj and Umrah. Travel Med Infect Dis. 13(2):159–166. https://doi.org/10.1016/j.tmaid.2014.12.005
  37. Guilhelmelli F, Vilela N, Albuquerque P, Derengowski LDS, Silva-Pereira I, Kyaw CM. 2013. Antibiotic development challenges: mechanisms of action of antimicrobial peptides and bacterial resistance. Front Microbiol. 4:353. https://doi.org/10.3389/fmicb.2013.00353
  38. Havelaar AH, Kirk MD, Torgerson PR, Gibb HJ, Hald T, Lake RJ, Praet N, Bellinger DC, de Silva NR, Gargouri N. 2015. World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med. 12(12):e1001923. https://doi.org/10.1371/journal.pmed.1001923
  39. Hayamo M, Alemayehu T, Tadesse B, Mitiku E, Bedawi Z. 2021. Magnitude, risk factors and antimicrobial susceptibility pattern of Shigella and Salmonella among children with diarrhea in Southern Ethiopia. SAGE Open Med. 9:20503121211009729. https://doi.org/10.1177/20503121211009729
  40. Helms A, Brodbelt JS. 2025. Progress in characterization of lipopolysaccharides and lipid A by mass spectrometry. Mass Spectrom Rev. https://doi.org/10.1002/mas.21842
  41. Hetta HF, Sirag N, Alsharif SM, Alharbi AA, Alkindy TT, Alkhamali A, Alanazi FE. 2024. Antimicrobial peptides: the game-changer in the battle against multidrug-resistant bacteria. Pharmaceuticals (Basel). 17(11):1555. https://doi.org/10.3390/ph17111555
  42. Howard-Varona C, Hargreaves KR, Abedon ST, Sullivan MB. 2017. Lysogeny in nature: mechanisms, impact and ecology of temperate phages. ISME J. 11(7):1511–1520. https://doi.org/10.1038/ismej.2017.16
  43. Islam S, Julie AS, Nazifa A, Khalil M, Asaduzzaman M. 2024. Synergistic effect of combination antibiotics against multidrug-resistant Salmonella enterica serovar Typhi. Dhaka Univ J Pharm Sci. 23(1):37–42. https://doi.org/10.3329/dujps.v23i1.72241
  44. Kakasis A, Panitsa G. 2019. Bacteriophage therapy as an alternative treatment for human infections: a comprehensive review. Int J Antimicrob Agents. 53(1):16–21. https://doi.org/10.1016/j.ijantimicag.2018.09.004
  45. Kalaria N, Upadhyay A, Kumar A. 2025. Synthetic compounds in disruption of Salmonella biofilm. (in press).
  46. Karmoker J, Saiful Islam M, Liton Rana M, Ashek Ullah M, Neloy FH, Oishy NM, Tanvir Rahman M. 2023. Molecular detection and multidrug resistance of Shigella spp. isolated from wild birds in Bangladesh. Vet Med Int. 2023:5374216. https://doi.org/10.1155/2023/5374216
  47. Kavanaugh LG, Dey D, Shafer WM, Conn GL. 2024. Structural and functional diversity of RND efflux pump transporters. Microbiol Mol Biol Rev. 88(3):e00089-23. https://doi.org/10.1128/mmbr.00089-23
  48. Kumavath R, Gupta P, Tatta ER, Mohan M, Salim SA, Busi S. 2025. Role of mobile genetic elements in antibiotic resistance transmission. Front Syst Biol. 5:1557413. https://doi.org/10.3389/fsysb.2025.1557413
  49. Lai TF, Ford RM, Huwiler SG. 2023. Advances in predatory biology of Bdellovibrio bacteriovorus. Front Microbiol. 14:1168709. https://doi.org/10.3389/fmicb.2023.1168709
  50. LeBoa C, Shrestha S, Shakya J, Naga SR, Shrestha S, Shakya M, Tamrakar D. 2023. Environmental sampling for typhoidal Salmonellas identifies transmission pathways. PLoS Negl Trop Dis. 17(10):e0011341. https://doi.org/10.1371/journal.pntd.0011341
  51. León Y, Honigsberg R, Rasko DA, Faherty CS. 2024. Gastrointestinal signals reveal adherence role in Shigella flexneri. Gut Microbes. 16(1):2331985. https://doi.org/10.1080/19490976.2024.2331985
  52. Levine MM, DuPont HL, Formal SB, Hornick RB, Takeuchi A, Gangarosa EJ, Libonati JP. 1973. Pathogenesis of Shigella dysenteriae 1 dysentery. J Infect Dis. 127(3):261–270. https://doi.org/10.1093/infdis/127.3.261
  53. Li Z, Zhang M, Lei G, Lu X, Yang X, Kan B. 2024. A single base change in the csgD promoter enhances biofilm in Salmonella Typhimurium. Microorganisms. 12(7):1258. https://doi.org/10.3390/microorganisms12071258
  54. Liu H, Zheng L, Fan H, Pang J. 2024. Genomic analysis of antibiotic resistance genes in nontyphoid Salmonella. mSystems. 9(9):e00586-24. https://doi.org/10.1128/msystems.00586-24
  55. MacKenzie KD, Palmer MB, Köster WL, White AP. 2017. Biofilm formation and host colonization by pathogenic Salmonella. Front Vet Sci. 4:138. https://doi.org/10.3389/fvets.2017.00138
  56. Malik MA, Albeladi SS, Al-Maaqar SM, Alshehri AA, Al-Thabaiti SA, Khan I, Kamli MR. 2023. Biosynthesis of Ag-Cu nanoparticles and antibacterial activity. Life (Basel). 13(3):653. https://doi.org/10.3390/life13030653
  57. Martinez-Soto CE, McClelland M, Kropinski AM, Lin JT, Khursigara CM, Anany H. 2024. Multireceptor phage cocktail against Salmonella enterica. MicroLife. 5:uqae003. https://doi.org/10.1093/femsml/uqae003
  58. Muturi P, Mbae C, Kibet E, Njoroge P, Kavai SM, Ideke D, Kariuki S. 2025. Antimicrobial resistance and biofilm formation in rarely reported Salmonella enterica serovars from patients in Nairobi, Kenya. Front Microbiol. 16:1628784. https://doi.org/10.3389/fmicb.2025.1628784
  59. Muzembo BA, Kitahara K, Mitra D, Ohno A, Khatiwada J, Dutta S, Miyoshi SI. 2023. Burden of Shigella in South Asia: a systematic review and meta-analysis. J Travel Med. 30(1):taac132. https://doi.org/10.1093/jtm/taac132
  60. Naser MS, Alkawaz AJ, Obaid AJ. 2025. Integrated analysis of global regulators and efflux genes in MDR Klebsiella pneumoniae. (in press).
  61. Ndip RA, Hanna JN, Mbah JA, Ghogomu SM, Ngemenya MN. 2023. In vitro synergistic activity of tetrahydroisoquinolines and antibiotics against MDR Salmonella. Adv Pharmacol Pharm Sci. 2023:6142810. https://doi.org/10.1155/2023/6142810
  62. Nickerson KP, Chanin RB, Sistrunk JR, Rasko DA, Fink PJ, Barry EM, Faherty CS. 2017. Analysis of Shigella flexneri resistance and biofilm formation in response to bile salts. Infect Immun. 85(6):e01000-16. https://doi.org/10.1128/IAI.01000-16
  63. Niyogi SK. 2005. Shigellosis. J Microbiol. 43(2):133–143.
  64. Novelli M, Bolla JM. 2024. RND efflux pump induction and adaptive antibiotic resistance mechanisms. Antibiotics (Basel). 13(6):501. https://doi.org/10.3390/antibiotics13060501
  65. Oliveira M, Madureira-Carvalho Á, Dinis-Oliveira RJ, Dias da Silva D. 2025. Non-antibiotic therapies for multidrug-resistant gastrointestinal infections. Front Antibiot. 4:1554061. https://doi.org/10.3389/frabi.2025.1554061
  66. Osose EB, Okeke OCO, Nnenna OE, Ndidi OK, Ikechukwu O, Francisca AU, Romanus II. 2025. Multidrug resistant Salmonella species harboring sulfonamide resistance genes in typhoid patients. Total Environ Microbiol. 100021.
  67. Pasqua M, Grossi M, Scinicariello S, Aussel L, Barras F, Colonna B, Prosseda G. 2019. The MFS efflux pump EmrKY contributes to survival of Shigella within macrophages. Sci Rep. 9(1):2906. https://doi.org/10.1038/s41598-019-39432-1
  68. Percival SL, Williams DW. 2014. Shigella. In: Microbiology of waterborne diseases. 2nd ed. London: Academic Press. p. 223–236.
  69. Peruzy MF, Murru N, Carullo MR, La Tela I, Rippa A, Balestrieri A, Proroga YTR. 2025. Antibiotic-resistant Salmonella circulation in Campania region (2010–2023). Antibiotics (Basel). 14(2):189. https://doi.org/10.3390/antibiotics14020189
  70. Phat VV, Lim AST, De Cozar-Gallardo C, Alvaro MIC, Alvarez DM, Alvaro EF, Baker S. 2025. High-throughput assay identifies antibacterial molecules against intracellular Shigella. npj Antimicrob Resist. 3(1):40. https://doi.org/10.1038/s44259-025-00040-9
  71. Piddock LJ. 2006. Multidrug-resistance efflux pumps: not just for resistance. Nat Rev Microbiol. 4(8):629–636. https://doi.org/10.1038/nrmicro1464
  72. Puangseree J, Hein ST, Prathan R, Srisanga S, Chuanchuen R. 2025. Genomic insights into multidrug-resistant Salmonella enterica from pets. Sci Rep. 15(1):22104. https://doi.org/10.1038/s41598-025-22104-3
  73. Puttagunta S, Aronin SI, DiFranco-Fisher J, Koeth L. 2023. Sulopenem disk development and MIC correlation for Enterobacterales. J Clin Microbiol. 61(7):e00246-23. https://doi.org/10.1128/jcm.00246-23
  74. Qaeed MA, Hendi A, Obaid AS, Thahe AA, Osman AM, Ismail A, Saif AEA. 2023a. Effect of Ocimum basilicum extracts on AgNP synthesis and antibacterial activity. Sci Rep. 13(1):5866. https://doi.org/10.1038/s41598-023-32866-5
  75. Qaeed MA, Hendi A, Thahe AA, Al-Maaqar SM, Osman AM, Ismail A, Al-Farga A. 2023b. Mentha spicata extracts in AgNP synthesis and antibacterial activity. J Nanomater. 2023:3599501. https://doi.org/10.1155/2023/3599501
  76. Ranjbar R, Farahani A. 2019. Shigella: antibiotic-resistance mechanisms and new horizons for treatment. Infect Drug Resist. 12:3137–3167. https://doi.org/10.2147/IDR.S224601
  77. Rezaei F, Nasser A, Azizi Jalilian F, Hobbs Z, Azizian R. 2014. Phage as a specific alternative against MRSA. Biosci Biotechnol Res Asia. 11(2):523–529. https://doi.org/10.13005/bbra/1322
  78. Ribeiro JM, Pereira GN, Durli Junior I, Teixeira GM, Bertozzi MM, Verri WA, Nakazato G. 2023. Phage cocktail development against multiple Salmonella serovars. Sci Rep. 13(1):13054. https://doi.org/10.1038/s41598-023-40239-4
  79. Rushdy AA, Sef FAA, Mabrouk MI, Kheiralla ZH, Abd El-All SM, Saleh NM. 2013. Antibiotic combinations against fluoroquinolone-resistant Salmonella enterica. (no DOI).
  80. Sargianou M, Stathopoulos P, Vrysis C, Tzvetanova ID, Falagas ME. 2025. New β-lactam/β-lactamase inhibitor combination antibiotics. Pathogens. 14(4):307. https://doi.org/10.3390/pathogens14040307
  81. Saudi Food and Drug Authority. 2024. National antimicrobial resistance reports 2023–2024. Riyadh: SFDA.
  82. Schumann A, Gaballa A, Wiedmann M. 2024. Roles of phosphoethanolamine-modified lipopolysaccharides. Microbiol Mol Biol Rev. 88(4):e00193-23. https://doi.org/10.1128/mmbr.00193-23
  83. Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Pickering LK. 2017. Clinical practice guidelines for infectious diarrhea. Clin Infect Dis. 65(12):e45–e80. https://doi.org/10.1093/cid/cix669
  84. Shi J, Chen C, Wang D, Wang Z, Liu Y. 2022. Antimicrobial peptide LI14 combats multidrug-resistant bacterial infections. Commun Biol. 5(1):926. https://doi.org/10.1038/s42003-022-03863-0
  85. Siddique A, Azim S, Ali A, Andleeb S, Ahsan A, Imran M, Rahman A. 2021. Antimicrobial resistance profiling of biofilm-forming non-typhoidal Salmonella. Antibiotics (Basel). 10(7):785. https://doi.org/10.3390/antibiotics10070785
  86. Sima CM, Buzilă ER, Trofin F, Păduraru D, Luncă C, Duhaniuc A, Năstase EV. 2024. Emerging strategies against non-typhoidal Salmonella. Curr Issues Mol Biol. 46(7):7447–7472. https://doi.org/10.3390/cimb46070469
  87. Sivanandy P, Yuk LS, Yi CS, Kaur I, Ern FHS, Manirajan P. 2024. Systematic review of outbreaks and treatment efficacy of drugs for Salmonella infections. IJID Reg. 100516. https://doi.org/10.1016/j.ijregi.2024.100516
  88. Smith AM. 2019. Bacterial gastroenteritis. In: Gastrointestinal diseases and their associated infections. p. 151.
  89. Soffer N, Woolston J, Li M, Das C, Sulakvelidze A. 2017. Bacteriophage preparation lytic for Shigella significantly reduces Shigella sonnei contamination in various foods. PLoS One. 12(3):e0175256. https://doi.org/10.1371/journal.pone.0175256
  90. Sukumaran AT, Nannapaneni R, Kiess A, Sharma CS. 2016. Reduction of Salmonella on chicken breast fillets stored under aerobic or modified atmosphere packaging using bacteriophage preparation. Poult Sci. 95(3):668–675. https://doi.org/10.3382/ps/pev327
  91. Taiwo SS. 2025. The rise of global antimicrobial resistance: impacts, responses and future prospects in Nigeria. Ann Trop Pathol. 16(1):1–18.
  92. Theuretzbacher U, Outterson K, Engel A, Karlén A. 2020. The global preclinical antibacterial pipeline. Nat Rev Microbiol. 18(5):275–285. https://doi.org/10.1038/s41579-019-0288-0
  93. Tilahun M, Belete MA, Gedefie A, Debash H, Alemayehu E, Weldehana DG, Shibabaw A. 2025. Prevalence of Salmonella and Shigella and multidrug resistance patterns among pediatric populations in Ethiopia. BMC Infect Dis. 25(1):52. https://doi.org/10.1186/s12879-024-10252-5
  94. Vaara M. 2020. Lipopolysaccharide and the permeability of the bacterial outer membrane. In: Endotoxin in health and disease. Boca Raton (FL): CRC Press. p. 31–38.
  95. Van Belleghem JD, Dąbrowska K, Vaneechoutte M, Barr JJ, Bollyky PL. 2018. Interactions between bacteriophage, bacteria, and the mammalian immune system. Viruses. 11(1): 10. https://doi.org/10.3390/v11010010
  96. Vena A, Castaldo N, Bassetti M. 2019. The role of new β-lactamase inhibitors in gram-negative infections. Curr Opin Infect Dis. 32(6):638–646. https://doi.org/10.1097/QCO.0000000000000598
  97. Wang Y, Xu X, Jia S, Qu M, Pei Y, Qiu S, Gao GF. 2025. A global atlas and drivers of antimicrobial resistance in Salmonella during 1900–2023. Nat Commun. 16(1):4611. https://doi.org/10.1038/s41467-025-4611-0
  98. Williams PC, Berkley JA. 2018. Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. Paediatr Int Child Health. 38(sup1):S50–S65. https://doi.org/10.1080/20469047.2017.1409454
  99. Wilson M, Wilson PJ. 2021. Gastroenteritis due to Salmonella. In: Close encounters of the microbial kind. Cham: Springer. p. 451–461. https://doi.org/10.1007/978-3-030-56917-7_20
  100. Yang C, Xiang Y, Qiu S. 2023. Resistance in enteric Shigella and nontyphoidal Salmonella: emerging concepts. Curr Opin Infect Dis. 36(5):360–365. https://doi.org/10.1097/QCO.0000000000000956
  101. Yarahmadi A, Najafiyan H, Yousefi MH, Khosravi E, Shabani E, Afkhami H, Aghaei SS. 2025. Beyond antibiotics: multifaceted approaches to combat bacterial resistance. Front Cell Infect Microbiol. 15:1493915. https://doi.org/10.3389/fcimb.2025.1493915
  102. Yeh Y, De Moura FH, Van Den Broek K, De Mello AS. 2018. Effect of ultraviolet light, organic acids, and bacteriophage on Salmonella populations in ground beef. Meat Sci. 139:44–48. https://doi.org/10.1016/j.meatsci.2017.12.012
  103. Zhou K, Sun L, Zhang X, Xu X, Mi K, Ma W, Huang L. 2023. Antimicrobial resistance in Salmonella: mechanisms and alternative therapeutic strategies. Front Microbiol. 14:1176317. https://doi.org/10.3389/fmicb.2023.1176317
DOI: https://doi.org/10.33073/pjm-2026-013 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 139 - 156
Submitted on: Dec 7, 2025
Accepted on: Mar 10, 2026
Published on: Jun 30, 2026
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Abdullah Ali Almrwani, Bassam O. Al-Johny, Ali Ahmad Shaibah, Adel M. Qumusani, Saleh M. Al-Maaqar, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.